Healthcare provider profile · identity verified

Sinon B Janay, MD

Family Practice · WOODBURY, MN · NPI 1689630923

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	652	180
Amlodipine Besylate	Amlodipine Besylate	266	80
Losartan Potassium	Losartan Potassium	237	68
Lisinopril	Lisinopril	208	64
Omeprazole	Omeprazole	197	66
Metoprolol Succinate	Metoprolol Succinate	160	46
Tamsulosin Hcl	Tamsulosin Hcl	114	38
Metformin Hcl Er	Metformin Hcl	110	35
Levothyroxine Sodium	Levothyroxine Sodium	90	22
Metformin Hcl	Metformin Hcl	86	27
Hydrochlorothiazide	Hydrochlorothiazide	82	26
Simvastatin	Simvastatin	82	22
Metoprolol Tartrate	Metoprolol Tartrate	81	21
Rosuvastatin Calcium	Rosuvastatin Calcium	71	23
Allopurinol	Allopurinol	66	19
Glipizide Er	Glipizide	66	18
Fluticasone Propionate	Fluticasone Propionate	63	22
Albuterol Sulfate Hfa	Albuterol Sulfate	56	26
Warfarin Sodium	Warfarin Sodium	55	12
Pantoprazole Sodium	Pantoprazole Sodium	51	18
Gabapentin	Gabapentin	49	17
Pravastatin Sodium	Pravastatin Sodium	49	17
Furosemide	Furosemide	48	16
Jardiance	Empagliflozin	48	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	12
Celecoxib	Celecoxib	43	17
Famotidine	Famotidine	43	13
Ozempic	Semaglutide	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	11
Eliquis	Apixaban	39	12
Tizanidine Hcl	Tizanidine Hcl	39	18
Sertraline Hcl	Sertraline Hcl	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	19
Escitalopram Oxalate	Escitalopram Oxalate	35	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Finasteride	Finasteride	31	suppressed
Carvedilol	Carvedilol	30	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Dutasteride	Dutasteride	24	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Prednisone	Prednisone	23	22
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Azithromycin	Azithromycin	21	19
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Cefuroxime	Cefuroxime Axetil	20	19
Glipizide	Glipizide	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	14
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Nitroglycerin	Nitroglycerin	19	14
Atenolol	Atenolol	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Naproxen	Naproxen	18	11
Alfuzosin Hcl Er	Alfuzosin Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Baclofen	Baclofen	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Naltrexone Hcl	Naltrexone Hcl	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Trazodone Hcl	Trazodone Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Potassium Chloride	Potassium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error